SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: - March 14, 2000
BIORELEASE CORP.
---------------
(Exact name of registrant as specified in charter)
Delaware 0-15260 88-0218411
-------- ------- ----------
Jurisdiction of Commission File I. R. S. Employer
Incorporation Number Identification
Number
340 Granite Street, Suite 200, Manchester, NH 03102
---------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number:
(603) 641-8443
Item 5. Other Events
On February 18, 2000, Biorelease Corp filed its quarterly report on Form 10-QSB.
In that report the company announced that the record date of March 15, 2000 had
been established for determination of the stockholders entitled to notice of and
to vote at a special meeting on the approval or disapproval of the PMC
transaction. The record date is herein changed to April 30, 2000 pending the
review and acceptance of the registration statement with the Securities and
Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIORELEASE CORP
/s/ R. Bruce Reeves, President
--------------------------------
Dated: March 14, 2000
